MetaCap

Rigel Pharmaceuticals Statistics

NASDAQ: RIGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

40.09-1.10 (-2.67%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Rigel Pharmaceuticals by the numbers

Rigel Pharmaceuticals has a market capitalization of $754.9 million based on 18.83M shares outstanding. Its trailing P/E ratio is 2.5, and its forward P/E is 8.4. The stock trades 14.5% below its 50-day average and 6.2% above its 200-day average.

Average daily trading volume is 248.06K shares, or about $9.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RIGL valuation vs. peer median

RIGL compared with the median of 8 peer companies
MetricRIGLPeer medianDifference
Market cap$754.89M$766.56M-2%
Forward P/E8.43.5+140%
Avg. volume248.06K2.28M-89%

Peer median across 8 companies: ARDX, IVA, ORIC, COLL, OBX, IRWD, SNDX, VSTM.

Valuation

Market cap
$754.89M
Price / sales (latest FY)
2.57
EPS (TTM)
$16.07

Price and trading

Previous close
41.19
Open
40.65
Day range
39.62 – 41.66
52-week range
24.95 – 52.61
52-week change
-13.26%
Beta
—
Volume
352.03K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
754.89M
Pe
2.49
Forward Pe
8.39
Eps
16.07
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
52.61
Week52 Low
24.95
Avg Volume
248.06K
Shares Outstanding
18.83M
Ma50
46.90
Ma200
37.76
Earnings Date
Nov 5, 2026
Pct From52w High
-23.80%
Pct From52w Low
60.68%

Related